Are you Dr. Lee?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 31 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Ave
Boston, MA 02115Phone+1 617-355-6000
Summary
- Dr. Pui Lee, MD is a pediatric rheumatologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Boston Children's Hospital and is a Clinical Fellow in Pediatrics at Boston Children's Hospital.
Education & Training
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Rheumatology, 2013 - 2016
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2010 - 2013
- University of Florida College of MedicineClass of 2010
Certifications & Licensure
- MA State Medical License 2013 - 2026
- American Board of Pediatrics Pediatric Rheumatology
Publications & Presentations
PubMed
- 25 citationsDisrupted N-linked glycosylation as a disease mechanism in deficiency of ADA2Pui Y. Lee, Yuelong Huang, Qing Zhou, Oskar Schnappauf, Michael S. Hershfield
The Journal of Allergy and Clinical Immunology. 2018-10-01 - 21 citationsComprehensive analysis of ADA2 genetic variants and estimation of carrier frequency driven by a function-based approachHyuk Jee, Z. Huang, Samantha Baxter, Yuelong Huang, Maria L. Taylor
The Journal of Allergy and Clinical Immunology. 2021-05-15 - 23 citationsTNF-inhibition in vasculitis management in adenosine deaminase 2 deficiency (DADA2).Natalie Deuitch, Dan Yang, Pui Y. Lee, Xiaomin Yu, Natalia Sampaio Moura
The Journal of Allergy and Clinical Immunology. 2021-11-12
Press Mentions
- ADA2 Is a Potent New Biomarker for Macrophage Activation SyndromeDecember 11th, 2019
- ADA2 Protein Is Reliable Marker of Macrophage Activation Syndrome in Systemic JIA, Study SuggestsNovember 15th, 2019
- ADA2 Is a Sensitive, Specific Biomarker for Life-Threatening Macrophage Activation Syndrome in Systemic JIANovember 10th, 2019
- Join now to see all